Enara Bio Email Format

Biotechnology ResearchEngland, United Kingdom51-200 Employees

Enara Bio is a mid-sized biotechnology company focused on cancer immunotherapy research. It aims to illuminate Dark Antigen biology and T-cell interactions to develop therapies for solid tumors. Its EDAPT platform seeks cancer-specific targets from previously uncharted genomic material, building a growing library of Dark Antigens for potential targeting. Through the EnTiCE platform, the company is advancing bispecific T cell engagers designed to target these Dark Antigen targets that are broadly present across solid tumors.

Based in Oxford, England, Enara Bio operates within the biotechnology research sector and collaborates with partners to advance immunotherapies for solid tumors. The company engages in collaborations such as with Boehringer Ingelheim to combine licensed Dark Antigens into novel immunotherapies. A recent development involved presenting preclinical data for ENA101, its bispecific T cell engager, at the AACR Annual Meeting 2026.

Get verified Enara Bio emails free

Company overview Employee directory